Trial Profile
Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFVIII Contained Regular Prophylaxis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms ReCARE
- Sponsors Bayer
- 16 Jul 2015 According to the Clinicaltrials.gov record, status changed from recruiting to completed.
- 10 Jul 2015 According to the Clinicaltrials.gov record, planned end date changed from 1 Jun 2015 to 1 Jul 2015.
- 10 Jul 2015 According to the Clinicaltrials.gov record, planned primary completion date changed from 1 Jun 2015 to 1 Jul 2015.